Table 4

Association Between Baseline Patient Characteristics, Process Variables, and Change in SBP for All Participants

MeasureMean SBPChangeP Value
Baseline6 Months
Diabetes
 Yes (n=68)161.0139.5−21.5
 No (n=136158.5136.5−22.0NS
English speaking
 Yes (n=98)160.9140.0−20.9
 No (n=106)157.9135.2−22.7NS
Black
 Yes (n=22)159.2137.3−21.9
 No (n=182)160.4139.6−20.8NS
Latino
 Yes (n=93)161.0140.0−21.0
 No (n=111)157.4134.6−22.7NS
Sex
 Female (n=129)158.6136.4−22.2
 Male (n=75)160.6139.4−21.2NS
SBP at baseline
 ≥160 mm Hg (n = 77)174.6143.7−30.9
 <160 mm Hg (n = 127)150.1133.8−16.3<.001
Number of blood pressure medications at baseline
 0 or 1 (n = 55)153.2134.4−18.8
 2 (n=75)160.9136.6−24.4
 ≥3 (n=74)162.3140.9−21.5NS
Number of coaching encounters
 1–5 (n=62)157.8140.6−17.2
 6–12 (n=68)158.8137.2−21.6
 >12 (n=74)161.1135.2−25.9.008
Number of medication changes
 0 (n=83)156.5136.2−20.3
 1 (n=50)159.4137.4−22.0
 ≥2 (n=71)162.6139.1−23.5NS
Change in number of medications from baseline to 6 months
 Fewer medications (n = 27)160.4145.0−15.3
 No change (n = 136)157.9135.6−22.3
 More medications (n = 41)163.5138.9−24.6.065
Change in number of days missed blood pressure medication from baseline to 6 months
 Fewer missed days (n = 21)159.5141.6−18.0
 No change (n = 119)159.4137.2−22.2
 More missed days (n = 27)161.3136.7−24.7NS
  • NS=nonsignificant; SBP = systolic blood pressure.

  • Note: Data were analyzed as for an observational study.